Cerity Partners’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.9K | Buy |
31,007
+1,103
| +4% | +$1.17K | ﹤0.01% | 2580 |
|
|
2025
Q1 | $23.6K | Sell |
29,904
-793,230
| -96% | -$627K | ﹤0.01% | 2439 |
|
|
2024
Q4 | $28.2K | Buy |
823,134
+806,846
| +4,954% | +$27.6K | ﹤0.01% | 2397 |
|
|
2024
Q3 | $57K | Buy |
16,288
+272
| +2% | +$952 | ﹤0.01% | 2477 |
|
|
2024
Q2 | $52.5K | Sell |
16,016
-790
| -5% | -$2.59K | ﹤0.01% | 2170 |
|
|
2024
Q1 | $123K | Sell |
16,806
-15,368
| -48% | -$113K | ﹤0.01% | 2178 |
|
|
2023
Q4 | $120K | Buy |
+32,174
| New | +$120K | ﹤0.01% | 1767 |
|
|
2023
Q3 | – | Sell |
-31,950
| Closed | -$152K | – | 1491 |
|
|
2023
Q2 | $152K | Buy |
+31,950
| New | +$152K | ﹤0.01% | 1514 |
|
|
2020
Q1 | – | Sell |
-10,070
| Closed | -$197K | – | 469 |
|
|
2019
Q4 | $197K | Buy |
+10,070
| New | +$197K | 0.01% | 508 |
|
|
2018
Q3 | – | Sell |
-13,920
| Closed | -$158K | – | 547 |
|
|
2018
Q2 | $158K | Hold |
13,920
| – | – | 0.01% | 520 |
|
|
2018
Q1 | $136K | Hold |
13,920
| – | – | 0.01% | 508 |
|
|
2017
Q4 | $85K | Hold |
13,920
| – | – | 0.01% | 551 |
|
|
2017
Q3 | $55K | Buy |
+13,920
| New | +$55K | ﹤0.01% | 563 |
|
|
2017
Q2 | – | Sell |
-13,920
| Closed | -$63K | – | 375 |
|
|
2017
Q1 | $63K | Buy |
+13,920
| New | +$63K | 0.01% | 430 |
|